Investing.com - Chemours Co (NYSE: CC) reported fourth quarter EPS of $0.00, $0.12 worse than the analyst estimate of $0.12. Revenue for the quarter came in at $1.3B versus the consensus estimate of $1.26B.
Chemours Co's stock price closed at $33.50. It is down -0.53% in the last 3 months and down -5.55% in the last 12 months.
Chemours Co saw 0 positive EPS revisions and 10 negative EPS revisions in the last 90 days. See Chemours Co's stock price’s past reactions to earnings here.
According to InvestingPro, Chemours Co's Financial Health score is "great performance".
Check out Chemours Co's recent earnings performance, and Chemours Co's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar